Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
NUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid tumors and is designed to determine the safety and the tolerability of doses of NUV-1511. In Phase 2, NUV-1511 will be given to determine the efficacy of patients with advanced solid tumors.
Sponsor: Nuvation Bio Inc.
Check if you qualify for this advanced solid tumors clinical trial in Seattle, WA
If you're searching for advanced solid tumors treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.